Griffin Asset Management, Inc. Gsk PLC Transaction History

Griffin Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$42.0 - $48.25 $217,896 - $250,321	-5,188 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$40.46 - $43.52 $82,659 - $88,911	-2,043 Reduced 28.25%	5,188 $221,000
Q2 2019 Aug 19, 2019	SELL	$39.4 - $42.7 $532,372 - $576,962	-13,512 Reduced 65.14%	7,231 $289,000
Q1 2019 May 08, 2019	BUY	$38.57 - $42.69 $3,239 - $3,585	84 Added 0.41%	20,743 $867,000
Q4 2018 Mar 01, 2019	SELL	$37.8 - $42.69 $47,628 - $53,789	-1,260 Reduced 5.75%	20,659 $789,000
Q3 2018 Nov 19, 2018	BUY	$39.75 - $42.69 $871,280 - $935,722	21,919 New	21,919 $880,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.